Paid Clinical Trials and Focus Groups by Location |
|
|
|
Condition: Idiopathic Menorrhagia
Interventions: Drug: Levonorgestrel (Mirena, BAY86-5028); Drug: Hormonal treatment; Drug: Antifibrinolytic treatment
Sponsor: Bayer
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin Glargine; Drug: LY2189265
Sponsor: Eli Lilly and Company
Recruiting - verified March 2010
Conditions: Secondary Hyperparathyroidism; Chronic Kidney Disease
Intervention: Drug: paricalcitol iv (Zemplar iv)
Sponsor: Abbott
Active, not recruiting - verified March 2010